Loyalty Options Prospectus
Released
Released
Announcement PDF
VENARI MINERALS NL
ACN 007 090 904
PROSPECTUS
For the offer of up to 8,139,303 New Options to the Placement Participants, Convertible
Noteholders and Consultants, as described in Section 1.2 (Offer).
IMPORTANT NOTICE
This document is important and should be read in its entirety. If, after reading this Prospectus you
have any questions about the Securities being offered under this Prospectus or any other matter,
then you should consult your professional advisers without delay.
The Securities offered by this Prospectus should be considered as highly speculative.
Not for release to US wire services or distribution in the United States.
5955-08/8924874_2 i
I M P O R T A N T N O TI C E
This Prospectus is dated 23 October 2026 and was
lodged with the ASIC on that date. The ASIC, ASX and
their respective officers take no responsibility for the
contents of this Prospectus or the merits of the
investment to which this Prospectus relates.
No Securities may be issued on the basis of this
Prospectus later than 13 months after the date of this
Prospectus.
No person is authorised to give information or to make
any representation in connection with this Prospectus,
which is not contained in this Prospectus. Any
information or representation not so contained may not
be relied on as having been authorised by the
Company in connection with this Prospectus.
It is important that investors read this Prospectus in its
entirety and seek professional advice where necessary.
The Securities offered by this Prospectus should be
considered as highly speculative.
This Prospectus is a transaction specific prospectus for an
offer of continuously quoted securities (as defined in the
Corporations Act) and has been prepared in
accordance with section 713 of the Corporations Act. It
does not contain the same level of disclosure as an
initial public offering prospectus and is only required to
contain information in relation to the effect of the issue
of securities on a company and the rights attaching to
the securities. It is not necessary to include general
information in relation to all of the assets and liabilities,
financial position, profits and losses or prospects of the
issuing company.
Representations contained in this Prospectus are made
taking into account that the Company is a disclosing
entity for the purposes of the Corporations Act and
certain matters are publicly available information or
may reasonably be expected to be known to investors
and professional advisers whom prospective investors
may consult.
No Investment Advice
The information contained in this Prospectus is not
financial product advice or investment advice and does
not take into account your financial or investment
objectives, financial situation or particular needs
(including financial or taxation issues). You should seek
professional advice from your accountant, financial
adviser, stockbroker, lawyer or other professional adviser
before deciding to subscribe for Securities under this
Prospectus to determine whether it meets your
objectives, financial situation and needs.
Forward-looking statements
This Prospectus contains forward-looking statements
which are identified by words such as ‘may’, ‘could’,
‘believes’, ‘estimates’, ‘targets’, ‘expects’, or ‘intends’
and other similar words that involve risks and
uncertainties.
These statements are based on an assessment of
present economic and operating conditions, and on a
number of assumptions regarding future events and
actions that, as at the date of this Prospectus, are
expected to take place.
Such forward-looking statements are not guarantees of
future performance and involve known and unknown
risks, uncertainties, assumptions and other important
factors, many of which are beyond the control of the
Company, the Directors and the Company’s
management.
The Company cannot and does not give any assurance
that the results, performance or achievements
expressed or implied by the forward-looking statements
contained in this Prospectus will actually occur and
investors are cautioned not to place undue reliance on
these forward-looking statements.
The Company has no intention to update or revise
forward-looking statements, or to publish prospective
financial information in the future, regardless of whether
new information, future events or any other factors
affect the information contained in this Prospectus,
except where required by law.
These forward-looking statements are subject to various
risk factors that could cause the Company’s actual
results to differ materially from the results expressed or
anticipated in these statements. These risk factors are
set out in Section 5.
Overseas investors
This Offer does not, and is not intended to, constitute an
offer in any place or jurisdiction in which, or to any
person to whom, it would not be lawful to make such an
offer or to issue this Prospectus.
The Offer is only being extended to the Placement
Participants, Convertible Noteholders and Consultants
described in Section 1.2, each of whom has a registered
address in a Permitted Jurisdiction. The distribution of this
Prospectus in jurisdictions outside Australia may be
restricted by law and persons who come into possession
of this Prospectus should seek advice on and observe
any such restrictions. For further information on the offer
restrictions that apply in each Permitted Jurisdiction
please refer to Section 2.9.
Continuous disclosure obligations
The Company is a “disclosing entity” (as defined in
section 111AC of the Corporations Act) for the purposes
of section 713 of the Corporations Act and, as such, is
subject to regular reporting and disclosure obligations.
Specifically, like all listed companies, the Company is
required to continuously disclose any information it has
to the market which a reasonable person would expect
to have a material effect on the price or the value of
the Securities.
This Prospectus is intended to be read in conjunction
with the publicly available information in relation to the
Company which has been notified to ASX and does not
include all of the information that would be included in
a prospectus for an initial public offering of securities in
an entity that is not already listed on a stock exchange.
Investors should therefore have regard to the other
publicly available information in relation to the
Company before making a decision whether or not to
invest.
Having taken such precautions and having made such
enquires as are reasonable, the Company believes that
it has complied with the general and specific
requirements of ASX as applicable from time to time
throughout the three months before the issue of this
Prospectus which required the Company to notify ASX of
information about specified events or matters as they
arise for the purpose of ASX making that information
available to the stock market conducted by ASX.
Please refer to Section 6.2 for further details.
Electronic Prospectus
A copy of this Prospectus can be downloaded from the
website of the Company at www.venariminerals.com. If
5955-08/8924874_2 ii
you are accessing the electronic version of this
Prospectus for the purpose of making an investment in
the Company, you must be a Placement Participant,
Convertible Noteholder or Consultant resident in a
Permitted Jurisdiction and must only access this
Prospectus from within that jurisdiction.
As set out in Section 2.1, the Offer is only extended to
the Placement Participants, Convertible Noteholders
and Consultants and personalised Application Forms will
be provided by the Company to those persons. You
may obtain a hard copy of this Prospectus free of
charge by contacting the Company by phone on +61 2
8046 2799 during office hours or by emailing the
Company at admin@venariminerals.com.
Company Website
No documents or other information available on the
Company’s website is incorporated into this Prospectus
by reference.
Financial forecasts
The Directors have considered the matters set out in
ASIC Regulatory Guide 170 and believe that they do not
have a reasonable basis to forecast future earnings on
the basis that the operations of the Company are
inherently uncertain. Accordingly, any forecast or
projection information would contain such a broad
range of potential outcomes and possibilities that it is
not possible to prepare a reliable best estimate forecast
or projection.
Clearing House Electronic Sub-Register System (CHESS)
and Issuer Sponsorship
The Company participates in CHESS, for those investors
who have, or wish to have, a sponsoring stockbroker.
Investors who do not wish to participate through CHESS
will be issuer sponsored by the Company.
Electronic sub-registers mean that the Company will not
be issuing certificates to investors. Instead, investors will
be provided with statements (similar to a bank account
statement) that set out the number of Securities issued
to them under this Prospectus. The notice will also
advise holders of their Holder Identification Number or
Security Holder Reference Number and explain, for
future reference, the sale and purchase procedures
under CHESS and issuer sponsorship.
Electronic sub-registers also mean ownership of securities
can be transferred without having to rely upon paper
documentation. Further monthly statements will be
provided to holders if there have been any changes in
their security holding in the Company during the
preceding month.
Photographs and Diagrams
Photographs used in this Prospectus which do not have
descriptions are for illustration only and should not be
interpreted to mean that any person shown endorses
the Prospectus or its contents or that the assets shown in
them are owned by the Company. Diagrams used in this
Prospectus are illustrative only and may not be drawn to
scale.
Definitions and Time
Unless the contrary intention appears or the context
otherwise requires, words and phrases contained in this
Prospectus have the same meaning and interpretation
as given in the Corporations Act and capitalised terms
have the meaning given in the Glossary in Section 8.
All references to time in this Prospectus are references to
Australian Eastern Daylight Time unless stated otherwise.
Privacy statement
By completing an Application Form, you are providing
personal information to the Company (directly or
through the share registry). The Company collects, holds
and will use that information to assess your application,
service your needs as a Shareholder and to facilitate
distribution payments and corporate communications to
you as a Shareholder.
The information may also be used from time to time and
disclosed to persons inspecting the register, including
bidders for your securities in the context of takeovers,
regulatory bodies including the Australian Taxation
Office, authorised securities brokers, print service
providers, mail houses and the share registry.
You can access, correct and update the personal
information that we hold about you. If you wish to do
so, please contact the share registry at the relevant
contact number set out in this Prospectus.
Collection, maintenance and disclosure of certain
personal information is governed by legislation including
the Privacy Act 1988 (as amended), the Corporations
Act and certain rules such as the ASX Settlement
Operating Rules. You should note that if you do not
provide the information required on the application for
Securities, the Company may not be able to accept or
process your application.
Enquiries
If you are in any doubt as to how to deal with any of the
matters raised in this Prospectus, you should consult with
your broker or legal, financial or other professional
adviser without delay. Should you have any questions
about the Offer or how to accept the Offer please call
the Company Secretary on +61 2 8046 2799.
5955-08/8924874_2 iii
C O R PO R A TE D IR EC TO R Y
Directors
Anthony Leibowitz
Executive Chairman
Matthew Healy
Executive Director and CEO
Vincent Fayad
Non-Executive Director
Joint Company Secretaries
Kurt Laney
Vincent Fayad
Registered Office
Suite 114-115, Level 1
165 Phillip Street
SYDNEY NSW 2000
Telephone: + 61 2 8046 2799
Email: admin@venariminerals.com
Website: www.venariminerals.com
Share Registry*
XCEND
Level 2, 477 Pitt Street
SYDNEY SOUTH NSW 2000
Telephone: +61 2 8591 8509
Legal advisers
Steinepreis Paganin
Level 14, QV1 Building
250 St Georges Terrace
PERTH WA 6000
Auditor*
RSM Australia Partners
Level 7, 1 Martin Place
SYDNEY NSW 2000
*These entities are included for information purposes only. They have not been involved in the preparation of this
Prospectus and have not consented to being named in this Prospectus.
5955-08/8924874_2 iv
T A B L E OF C O N T E N TS
1. KEY OFFER INFORMATION ............................................................................................................. 1
2. DETAILS OF THE OFFER ................................................................................................................... 3
3. PURPOSE AND EFFECT OF THE OFFER............................................................................................ 6
4. RIGHTS AND LIABILITIES ATTACHING TO SECURITIES ................................................................... 8
5. RISK FACTORS............................................................................................................................... 14
6. ADDITIONAL INFORMATION........................................................................................................ 20
7. DIRECTORS’ AUTHORISATION...................................................................................................... 25
8. GLOSSARY .................................................................................................................................... 26
5955-08/8924874_2 1
1. KEY OFFER INFORMATION
1.1 Timetable
ACTION DATE
Lodgement of Prospectus with the ASIC and ASX 23 October 2026
Opening Date 23 October 2026
Closing Date of Offer* 30 October 2026
Expected date for quotation of New Options on ASX*
(excluding the New Director Options)
2 November 2026
Annual General Meeting 23 November 2026
Expected date for quotation of New Director Options
on ASX**
24 November 2026
* These dates are indicative only and may change without notice. The Directors reserve the right to
extend the Closing Date or close an Offer at any time after the Opening Date without notice.
** Subject to the Director Resolutions being passed.
1.2 Background to the Offer
On 20 July 2026, the Company announced a capital raising of $6,100,000 (before costs),
comprising a two tranche placement of Shares to raise $4,750,000, and the issue of
convertible notes to raise $1,350,000 (together, the Capital Raising).
(a) Placement
As announced on 31 July 2026 and 25 September 2026, the Company secured
funding of A$4,750,000 (before associated costs) by a placement of 59,375,000
Shares (Placement Shares) to sophisticated and professional investors, and
Directors Anthony Leibowitz, Vince Fayad and Matthew Healy, at an issue price
of $0.08 per Placement Share (Placement). The Placement Shares were issued
to non-related participants using the Company’s available placement capacity
under ASX Listing Rules 7.1 and 7.1A, and pursuant to Shareholder approval
under ASX Listing Rule 7.1. The Placement Shares were issued to the Directors
pursuant to Shareholder approval under ASX Listing Rule 10.11.
The Company has agreed to issue one (1) free attaching New Option for every
ten (10) Placement Shares subscribed for and issued under the Placement.
Shareholder approval for the issue of the New Options to the Placement
Participants was obtained at the Company’s general meeting held on
11 September 2026 (General Meeting).
Under the Offer, the Company is offering 5,937,500 New Options to the
participants that subscribed for and were allocated Placement Shares under
the Placement (including the Directors) (Placement Participants). Of those New
Options, 326,250 are to be issued to the Directors (or their nominees) (New
Director Options), subject to Shareholder approval.
(b) Convertible Note Subscription Agreements
As the second component of the Capital Raising, on 27 July 2026 the Company
entered into subscription agreements (Subscription Agreements) with Pershing
Nominees Limited, as nominee for each of Stenham Select Holdings Limited and
Vienna Entertainment Ltd, being entities controlled by Mr Kevin Arenson
(together, the Convertible Noteholders), under which the Company agreed to
issue the Convertible Noteholders convertible notes with an aggregate face
value of $1,350,000 (Convertible Notes), subject to Shareholder approval. Each
Convertible Note is convertible into Shares at a conversion price of $0.08 per
Share, being the issue price of the Placement Shares.
In consideration for subscribing for the Convertible Notes, the Company agreed
to issue the Convertible Noteholders an aggregate of 1,687,500 New Options,
being one (1) New Option for every ten (10) Shares into which the Convertible
5955-08/8924874_2 2
Notes may convert. Shareholder approval for the issue of the Convertible Notes
and of the New Options to the Convertible Noteholders was obtained at the
General Meeting.
(c) Consultants
The Company also engaged a number of consultants (Consultants) to assist
with the Capital Raising. In consideration for that assistance, the Company
agreed to issue the Consultants an aggregate of 514,303 New Options on the
same terms as the New Options offered to the Placement Participants and the
Convertible Noteholders.
The Company's arrangement with the Consultants is not documented in a formal written
agreement. The agreement to issue the New Options to the Consultants was ratified by
Shareholders at the General Meeting. Further details in respect of these issues are set out
in the notice of General Meeting released on 13 August 2026.
1.3 Shareholder approval for New Director Options
At the General Meeting, Shareholders approved the issue of the New Director Options for
the purposes of ASX Listing Rule 10.11. The New Director Options were not issued within
one month after the General Meeting, as required by the Listing Rules, and that approval
has lapsed. The Company intends to seek fresh Shareholder approval for the issue of the
New Director Options (Director Resolutions) at its annual general meeting to be held on
23 November 2026 (AGM). The Director Resolutions will be put to Shareholders by way of
an addendum to the notice of AGM, which the Company expects to release on or
before 12 November 2026.
5955-08/8924874_2 3
2. DETAILS OF THE OFFER
2.1 The Offer
The Offer is for up to 8,139,303 New Options and is available for application by the
specific parties set out in Section 1.2.
The Offer will only be extended to the Placement Participants, Convertible Noteholders
and Consultants as set out in Section 1.2 above. Accordingly, Application Forms in
relation to the Offer will only be provided by the Company to these eligible participants.
The New Options to be issued under the Offer will be issued on the terms and conditions
set out in Section 4.1.
The issue of the New Director Options is subject to, and conditional on, the Director
Resolutions being passed at the AGM. If the Director Resolutions are not passed, the New
Director Options will not be issued. For further details on the Shareholder approval
required for the issue of the New Director Options refer to Section 1.3 above.
Any Shares issued upon the future exercise of New Options will rank equally with the
Shares on issue at the date of this Prospectus. Please refer to Section 4.2 for further
information regarding the rights and liabilities attaching to Shares.
No funds will be raised under the Offer as the New Options are being issued for nil cash
consideration, either free attaching to the Placement Shares, in consideration for the
subscription for the Convertible Notes or in consideration for services provided in
connection with the Capital Raising. If all of the New Options are issued and
subsequently exercised, the Company would receive approximately $976,716.
The New Options will be issued on the same terms as, and on issue will form part of the
same class of quoted Options as, the Company’s existing quoted Options (ASX: VMSOA).
The Company will apply for Official Quotation of the New Options in that class.
2.2 Minimum subscription
There is no minimum subscription.
2.3 Underwriting
The Offer is not underwritten.
2.4 Applications under the Offer
The Offer will only be extended and Application Forms will only be provided to the
specific parties set out in Section 2.1.
Applications for New Options under the Offer must only be made using the Application
Form provided by the Company with this Prospectus.
Placement Participants, Convertible Noteholders and Consultants must lodge their
completed Application Form as directed.
No payment is required to subscribe for New Options under the Offer.
All applications under the Offer, once received, are irrevocable.
The Company reserves all discretions in relation to applications in the Offer.
2.5 Implications of an application
By completing an Application Form, applicants will be taken to have declared that all
details and statements made by them are complete and accurate and that they have
personally received the Application Form together with a complete and unaltered copy
of this Prospectus.
Completed Application Forms must be returned in accordance with the instructions on
the Application Form, with sufficient time to be received by or on behalf of the Company
by no later than 5.00pm (AEDT) on the Closing Date.
5955-08/8924874_2 4
If you require assistance in completing an Application Form, please contact the
Company on +61 2 8046 2799.
2.6 ASX listing
Application for Official Quotation of the New Options offered pursuant to this Prospectus
will be made within 7 days after the date of this Prospectus. The New Options will, on
issue, form part of the same class of quoted Options as the Company’s existing quoted
Options (ASX: VMSOA). If ASX does not grant Official Quotation of the New Options
offered pursuant to this Prospectus before the expiration of three months after the date
of issue of the Prospectus, (or such period as varied by the ASIC), the Company will not
issue any New Options under the Offer.
The fact that ASX may grant Official Quotation to the New Options is not to be taken in
any way as an indication of the merits of the Company or the Securities now offered for
subscription.
2.7 Issue
The issue of New Options under the Offer is anticipated to take place in accordance with
the ASX Listing Rules and the indicative timetable set out at Section 1.1.
The New Director Options will only be issued if the Director Resolutions are passed at the
AGM.
Holding statements for the New Options issued under the Offer will be mailed as soon as
practicable after the date of issue.
2.8 Defects in Application Forms
If an Application Form is not completed correctly, the Company may, in its sole
discretion, still treat the Application Form to be valid. The Company’s decision to treat an
application as valid, or how to construe, amend or complete it, will be final.
2.9 Overseas shareholders
This Prospectus does not constitute an offer of New Options in any jurisdiction in which it
would be unlawful. The Offer is only being extended to Placement Participants,
Convertible Noteholders and Consultants with registered addresses in the Permitted
Jurisdictions, subject to the restrictions set out below.
The distribution of this Prospectus outside Australia may be restricted by law and
therefore persons into whose possession this document comes should seek advice on
and observe any such restrictions. Any failure to comply with these restrictions constitutes
a violation of those laws.
Accordingly, the Offer is not being extended and New Options will not be issued to any
person with a registered address outside the Permitted Jurisdictions, and New Options will
only be issued to Placement Participants, Convertible Noteholders and Consultants in the
Permitted Jurisdictions outside Australia to the extent permitted below.
Gibraltar
This document may not be made available, nor may the Options be offered for sale, in
Gibraltar except in circumstances that do not require the obligation to publish a
prospectus under the Companies Act 2014. This document has not been, and will not be,
lodged for approval with the Gibraltar Financial Services Commission or the Companies
Registrar in Gibraltar. This document may be distributed, and the Options may be issued,
only to fewer than 50 participants in the share placement with registered addresses in
Gibraltar.
Jersey
No offer or invitation to subscribe for equity securities may be made to the public in
Jersey. The Options will be offered in Jersey only to investors who participated in the
Company’s recent share placement and to the extent they constitute fewer than 50
persons.
5955-08/8924874_2 5
Mauritius
In accordance with the Securities Act 2005 of Mauritius, no offer of Options may be
made to the public in Mauritius without the prior approval of the Mauritius Financial
Services Commission. Accordingly, an offer of Options is being made on a private
placement basis only to “sophisticated investors” (as defined in the Securities Act 2005)
and does not constitute a public offering in Mauritius. As such, this document has not
been approved or registered by the Mauritius Financial Services Commission and is for
the exclusive use of sophisticated investors. The document may not be distributed to
other persons in Mauritius.
Singapore
This document and any other materials relating to the Options have not been, and will
not be, lodged or registered as a prospectus in Singapore with the Monetary Authority of
Singapore. Accordingly, this document and any other document or materials in
connection with the offer or sale, or invitation for subscription or purchase, of Options,
may not be issued, circulated or distributed, nor may the Options be offered or sold, or
be made the subject of an invitation for subscription or purchase, whether directly or
indirectly, to persons in Singapore except pursuant to and in accordance with
exemptions in Subdivision (4) Division 1, Part 13 of the Securities and Futures Act 2001 of
Singapore (the “SFA”) or another exemption under the SFA.
This document has been given to you on the basis that you are an “institutional investor”
or an “accredited investor” (as such terms are defined in the SFA). If you are not such an
investor, please return this document immediately. You may not forward or circulate this
document to any other person in Singapore.
Any offer is not made to you with a view to the Options or the underlying shares being
subsequently offered for sale to any other party in Singapore. On-sale restrictions in
Singapore may be applicable to investors who acquire such securities. As such, investors
are advised to acquaint themselves with the SFA provisions relating to resale restrictions in
Singapore and comply accordingly.
South Africa
This document does not, nor is it intended to, constitute a prospectus prepared and
registered under the South African Companies Act 2008 and may not be distributed to
the public in South Africa. This document has not been registered with nor approved by
the South African Companies and Intellectual Property Commission.
Any offer of Options in South Africa will be made by way of a private placement to, and
capable of acceptance only by, investors who fall within one of the specified categories
listed in section 96(1)(a) of the South African Companies Act.
An entity or person resident in South Africa may not implement participation in the offer
unless (i) permitted under the South African Exchange Control Regulations or (ii) a
specific approval has been obtained from an authorised foreign exchange dealer in
South Africa or the Financial Surveillance Department of the South African Reserve Bank.
5955-08/8924874_2 6
3. PURPOSE AND EFFECT OF THE OFFER
3.1 Purpose of the Offer
The purpose of the Offer is to remove any trading restrictions attaching to the New
Options issued under the Offer and any Shares issued on exercise of these New Options,
given that the New Options offered under the Offer are being issued with disclosure
under this Prospectus.
Subject to ASX granting Official Quotation of the New Options, this will allow holders to
trade the New Options on the ASX and ensure that any Shares issued on exercise of the
New Options can be on-sold within 12 months of their issue, without a disclosure
document for the on-sale offer.
No funds will be raised directly under the Offer as the New Options are being issued for nil
cash consideration, either free attaching to the Placement Shares, in consideration for
the subscription for the Convertible Notes or in consideration for services provided in
connection with the Capital Raising. However, if all of the New Options are exercised, the
Company will receive approximately $976,716 in aggregate by virtue of payment of the
Exercise Price. Should any funds be received from the exercise of the New Options, the
use of those funds will be determined at the time of receipt and is expected to be
applied towards the Company’s existing business operations and working capital at that
time.
The principal effect of the Offer, assuming all New Options offered under the Offer are
issued, will be to increase the total number of Options on issue by 8,139,303 on
completion of the Offer.
3.2 Effect on capital structure
The effect of the Offer on the capital structure of the Company is set out below.
Shares
NUMBER
Shares currently on issue1 168,091,637
Shares offered pursuant to the Offer Nil
Total Shares on issue after completion of the Offer 168,091,637
Notes:
1. The rights and liabilities attaching to the Shares are summarised in Section 4.2.
Options
NUMBER
Options currently on issue1 13,219,160
New Options to be issued pursuant to th
Share your feedback
Discover